{"title":"GMP Guides for QC Labs | Data Integrity, Pharmacopeias, Audits","description":"\u003cp\u003eOperational guides for pharmaceutical QC laboratories: Data Integrity, Audit Trail Review, USP\/Ph.Eur. pharmacopeias, analytical methods and GMP compliance.\u003c\/p\u003e","products":[{"product_id":"alcoa-data-governance-la-guida-operativa-definitiva-per-la-data-integrity-pharma","title":"ALCOA+ \u0026 Data Governance – The Definitive Operational Guide for Pharmaceutical Data Integrity","description":"\u003cp data-start=\"254\" data-end=\"614\"\u003eThe most comprehensive guide for QA, QC, IT, Manufacturing and Validation professionals who must implement a solid, modern and fully compliant Data Integrity system.\u003cbr data-start=\"419\" data-end=\"422\"\u003eIt provides an operational walkthrough of ALCOA+ principles, Data Governance, the Data Lifecycle and the full Data Integrity Risk Assessment (DIRA) process required by international standards.\u003c\/p\u003e\n\u003cp data-start=\"616\" data-end=\"641\"\u003e\u003cstrong data-start=\"616\" data-end=\"641\"\u003eInside you will find:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"643\" data-end=\"1442\"\u003e📌 \u003cstrong data-start=\"646\" data-end=\"698\"\u003ePractical explanation of the 9 ALCOA+ attributes\u003c\/strong\u003e, with examples and application across GMP departments.\u003cbr data-start=\"753\" data-end=\"756\"\u003e🏛️ \u003cstrong data-start=\"760\" data-end=\"785\"\u003eData Governance model\u003c\/strong\u003e including roles, responsibilities, KPIs and integration within the PQS.\u003cbr data-start=\"857\" data-end=\"860\"\u003e🔄 \u003cstrong data-start=\"863\" data-end=\"909\"\u003eComplete management of the Data Lifecycle:\u003c\/strong\u003e generation → recording → processing → archiving → retrieval.\u003cbr data-start=\"970\" data-end=\"973\"\u003e🛡️ \u003cstrong data-start=\"977\" data-end=\"1032\"\u003eStructured methodology to conduct an effective DIRA\u003c\/strong\u003e, with typical risks and actionable mitigations.\u003cbr data-start=\"1080\" data-end=\"1083\"\u003e⚠️ \u003cstrong data-start=\"1086\" data-end=\"1125\"\u003eCommon issues identified by FDA\/EMA\u003c\/strong\u003e (backdating, uncontrolled copies, disabled audit trails, unqualified data migrations).\u003cbr data-start=\"1212\" data-end=\"1215\"\u003e📝 \u003cstrong data-start=\"1218\" data-end=\"1245\"\u003eProfessional templates:\u003c\/strong\u003e DIRA form, Data Integrity SOP, Audit Trail Review log, data-flow inventory, audit checklist.\u003cbr data-start=\"1338\" data-end=\"1341\"\u003e🔍 \u003cstrong data-start=\"1344\" data-end=\"1368\"\u003eAudit-ready approach\u003c\/strong\u003e for EMA\/FDA inspections, with real examples of observed non-conformities.\u003c\/p\u003e\n\u003cp data-start=\"1444\" data-end=\"1565\"\u003ePerfect for QA Managers, QC Analysts, Data Owners, IT\/CSV Specialists, Production Supervisors and Validation Specialists.\u003c\/p\u003e\n\u003cp data-start=\"1567\" data-end=\"1676\"\u003e\u003cstrong data-start=\"1567\" data-end=\"1578\"\u003eFormat:\u003c\/strong\u003e Professional PDF\u003cbr data-start=\"1595\" data-end=\"1598\"\u003e\u003cstrong data-start=\"1598\" data-end=\"1609\"\u003eLength:\u003c\/strong\u003e 92 pages\u003cbr data-start=\"1618\" data-end=\"1621\"\u003e\u003cstrong data-start=\"1621\" data-end=\"1633\"\u003eUpdated:\u003c\/strong\u003e December 2025\u003cbr data-start=\"1647\" data-end=\"1650\"\u003e\u003cstrong data-start=\"1650\" data-end=\"1664\"\u003eLanguages:\u003c\/strong\u003e ITA – ENG\u003c\/p\u003e\n\u003cp data-start=\"1678\" data-end=\"1713\"\u003e\u003cstrong data-start=\"1678\" data-end=\"1713\"\u003eDOWNLOAD A PREVIEW OF THE GUIDE\u003c\/strong\u003e\u003c\/p\u003e\n\u003ctable class=\"MsoTableGrid\" border=\"1\" cellspacing=\"0\" cellpadding=\"0\" width=\"54%\" style=\"width: 54.1%; border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt;\"\u003e\n\u003ctbody\u003e\n\u003ctr style=\"mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes;\"\u003e\n\u003ctd width=\"48%\" valign=\"top\" style=\"width: 48.2%; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\"\u003e\n\u003cp class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 115%; text-align: center;\"\u003e\u003ca rel=\"noopener\" title=\"ALCOA+ \u0026amp; Data Governance – La Guida Operativa Definitiva per la Data Integrity Pharma\" href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/ALCOA_Data_Governance_PREVIEW_ITA.pdf?v=1764867342\" target=\"_blank\"\u003e\u003cb\u003ePreview ITA \u003c\/b\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd width=\"50%\" valign=\"top\" style=\"width: 50.9%; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\"\u003e\n\u003cp class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 115%; text-align: center;\"\u003e\u003ca rel=\"noopener\" title=\"ALCOA+ \u0026amp; Data Governance – La Guida Operativa Definitiva per la Data Integrity Pharma\" href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/ALCOA_operational_Guide_to_Data_Integrity_ENG_PREVIEW.pdf?v=1764867387\" target=\"_blank\"\u003e\u003cb\u003ePreview ENG\u0026nbsp;\u003c\/b\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e","brand":"GuideGxP","offers":[{"title":"ENG - English","offer_id":53516225511754,"sku":null,"price":49.0,"currency_code":"EUR","in_stock":true},{"title":"ITA- Italiano","offer_id":53516225544522,"sku":null,"price":49.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/Guida_ALCOA_E_DATA_INTEGRITY_COVER_8abde91f-3fe2-443e-9a0a-c636616c841b.png?v=1764867282"},{"product_id":"audit-trail-review-step-by-step-la-guida-operativa-definitiva-per-qc-e-produzione","title":"Audit Trail Review Step-by-Step – The Definitive Operational Guide for QC and Manufacturing","description":"\u003cp data-start=\"245\" data-end=\"586\"\u003eThe most comprehensive guide for QA, QC, Manufacturing and Validation professionals who must perform a compliant, effective and truly useful Audit Trail Review to support Data Integrity.\u003cbr data-start=\"431\" data-end=\"434\"\u003eIt clearly explains what to check, how to document the review and how to meet FDA, EMA, PIC\/S and MHRA expectations in QC and Manufacturing departments.\u003c\/p\u003e\n\u003cp data-start=\"588\" data-end=\"613\"\u003e\u003cstrong data-start=\"588\" data-end=\"613\"\u003eInside you will find:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"615\" data-end=\"1505\"\u003e🔍 \u003cstrong data-start=\"618\" data-end=\"676\"\u003eOperational explanation of what an audit trail records\u003c\/strong\u003e and why it is essential for ALCOA+ and Data Integrity.\u003cbr data-start=\"731\" data-end=\"734\"\u003e🧪 \u003cstrong data-start=\"737\" data-end=\"802\"\u003ePractical guidance for conducting an Audit Trail Review in QC\u003c\/strong\u003e (HPLC, GC, UV, LIMS), with real examples of anomalies.\u003cbr data-start=\"857\" data-end=\"860\"\u003e🏭 \u003cstrong data-start=\"863\" data-end=\"917\"\u003eProcedures and controls to apply in Manufacturing:\u003c\/strong\u003e batch records, supervision systems, electronic equipment and MES.\u003cbr data-start=\"983\" data-end=\"986\"\u003e⚠️ \u003cstrong data-start=\"989\" data-end=\"1043\"\u003eCritical errors identified by inspectors (FDA\/EMA)\u003c\/strong\u003e and red flags to detect immediately: inconsistent timestamps, missing reasons for change, post-approval modifications, unauthorized access.\u003cbr data-start=\"1183\" data-end=\"1186\"\u003e📋 \u003cstrong data-start=\"1189\" data-end=\"1258\"\u003eOperational checklists for a complete and well-documented review:\u003c\/strong\u003e QC, Manufacturing, IT, QA.\u003cbr data-start=\"1285\" data-end=\"1288\"\u003e🛡️ \u003cstrong data-start=\"1292\" data-end=\"1314\"\u003eAudit-ready model:\u003c\/strong\u003e how to present the Audit Trail during an inspection and how to provide solid evidence.\u003cbr data-start=\"1401\" data-end=\"1404\"\u003e📝 \u003cstrong data-start=\"1407\" data-end=\"1430\"\u003eIncluded templates:\u003c\/strong\u003e Audit Trail Review form, anomaly log, decision flowchart, example entries.\u003c\/p\u003e\n\u003cp data-start=\"1507\" data-end=\"1615\"\u003ePerfect for QA Managers, QC Analysts, Data Reviewers, Production Supervisors and Validation\/CSV Specialists.\u003c\/p\u003e\n\u003cp data-start=\"1617\" data-end=\"1720\"\u003e\u003cstrong data-start=\"1617\" data-end=\"1628\"\u003eFormat:\u003c\/strong\u003e Professional PDF\u003cbr data-start=\"1645\" data-end=\"1648\"\u003e\u003cstrong data-start=\"1648\" data-end=\"1658\"\u003ePages:\u003c\/strong\u003e 118\u003cbr data-start=\"1662\" data-end=\"1665\"\u003e\u003cstrong data-start=\"1665\" data-end=\"1677\"\u003eUpdated:\u003c\/strong\u003e December 2025\u003cbr data-start=\"1691\" data-end=\"1694\"\u003e\u003cstrong data-start=\"1694\" data-end=\"1708\"\u003eLanguages:\u003c\/strong\u003e ITA – ENG\u003c\/p\u003e\n\u003cp data-start=\"1722\" data-end=\"1757\"\u003e\u003cstrong data-start=\"1722\" data-end=\"1757\"\u003eDOWNLOAD A PREVIEW OF THE GUIDE\u003c\/strong\u003e\u003c\/p\u003e\n\u003ctable style=\"width: 54.1%; border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt;\" width=\"54%\" cellpadding=\"0\" cellspacing=\"0\" border=\"1\" class=\"MsoTableGrid\"\u003e\n\u003ctbody\u003e\n\u003ctr style=\"mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes;\"\u003e\n\u003ctd style=\"width: 48.2%; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"48%\"\u003e\n\u003cp style=\"margin-bottom: 8pt; line-height: 115%; text-align: center;\" class=\"MsoNormal\"\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/Guida_Operativa_Avanzata_Audit_Trail_Review_PREVIEW.pdf?v=1764867713\" title=\"Audit Trail Review Step-by-Step – La Guida Operativa Definitiva per QC e Produzione\" rel=\"noopener\" target=\"_blank\"\u003e\u003cb\u003ePreview ITA \u003c\/b\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd style=\"width: 50.9%; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"50%\"\u003e\n\u003cp style=\"margin-bottom: 8pt; line-height: 115%; text-align: center;\" class=\"MsoNormal\"\u003e\u003cb\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/GUIDE_Audit_Trail_Review_in_GxP_QC_and_Production_ENG_PREVIEW.pdf?v=1764867774\" title=\"Audit Trail Review Step-by-Step – La Guida Operativa Definitiva per QC e Produzione\" rel=\"noopener\" target=\"_blank\"\u003ePreview ENG\u003c\/a\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/ALCOA_operational_Guide_to_Data_Integrity_ENG_PREVIEW.pdf?v=1764867387\" title=\"ALCOA+ \u0026amp; Data Governance – La Guida Operativa Definitiva per la Data Integrity Pharma\" rel=\"noopener\" target=\"_blank\"\u003e\u0026nbsp;\u003c\/a\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e","brand":"GuideGxP","offers":[{"title":"ENG - English","offer_id":53516843254090,"sku":null,"price":49.0,"currency_code":"EUR","in_stock":true},{"title":"ITA - Italiano","offer_id":53516843286858,"sku":null,"price":49.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/GUIDE_Audit_Trail_Review_in_GxP_QC_and_Production_ENG_COVER.png?v=1764868016"},{"product_id":"data-integrity-in-qc-labs-hplc-gc-empower-lims-eln-guida-operativa-audit-ready","title":"Data Integrity in QC Labs – HPLC, GC, Empower, LIMS, ELN","description":"\u003cp data-start=\"242\" data-end=\"427\"\u003eThe most comprehensive guide for QA, QC, Laboratory Supervisors and Data Reviewers who must ensure compliant, robust and audit-ready data management within Quality Control laboratories.\u003c\/p\u003e\n\u003cp data-start=\"429\" data-end=\"675\"\u003eIt covers step by step all critical QC systems and data flows — HPLC, GC, Empower, LIMS, ELN, balances, dissolution, UV\/IR, data review, OOS\/OOT, backup and audit readiness — with a practical approach aligned with FDA, EMA and PIC\/S expectations.\u003c\/p\u003e\n\u003cp data-start=\"677\" data-end=\"702\"\u003e\u003cstrong data-start=\"677\" data-end=\"702\"\u003eInside you will find:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"704\" data-end=\"1809\"\u003e🔬 \u003cstrong data-start=\"707\" data-end=\"736\"\u003eHPLC \u0026amp; GC Data Integrity:\u003c\/strong\u003e raw data, metadata, peak integration, reprocessing, common errors and what inspectors look for.\u003cbr data-start=\"832\" data-end=\"835\"\u003e🧪 \u003cstrong data-start=\"838\" data-end=\"865\"\u003eEmpower Data Integrity:\u003c\/strong\u003e data structure, audit trail, typical errors and step-by-step best practices.\u003cbr data-start=\"942\" data-end=\"945\"\u003e📚 \u003cstrong data-start=\"948\" data-end=\"963\"\u003eLIMS \u0026amp; ELN:\u003c\/strong\u003e risks, key controls, correct configurations and practical applications.\u003cbr data-start=\"1035\" data-end=\"1038\"\u003e⚙️ \u003cstrong data-start=\"1041\" data-end=\"1066\"\u003eOther QC instruments:\u003c\/strong\u003e dissolution, UV\/VIS, FTIR, balances, pH meters, loggers — with errors to avoid and key takeaways.\u003cbr data-start=\"1164\" data-end=\"1167\"\u003e📝 \u003cstrong data-start=\"1170\" data-end=\"1195\"\u003eComplete Data Review:\u003c\/strong\u003e primary review, secondary review, verification checklists and red flags to identify immediately.\u003cbr data-start=\"1292\" data-end=\"1295\"\u003e📉 \u003cstrong data-start=\"1298\" data-end=\"1327\"\u003eIntegration with OOS\/OOT:\u003c\/strong\u003e how to properly manage atypical results, investigations and data-related impacts.\u003cbr data-start=\"1409\" data-end=\"1412\"\u003e💾 \u003cstrong data-start=\"1415\" data-end=\"1443\"\u003eBackup \u0026amp; Data Lifecycle:\u003c\/strong\u003e controls, policies, compensatory measures and regulatory expectations.\u003cbr data-start=\"1514\" data-end=\"1517\"\u003e🛡️ \u003cstrong data-start=\"1521\" data-end=\"1544\"\u003eQC Audit Readiness:\u003c\/strong\u003e what FDA\/EMA inspectors really assess, how to respond and which evidence must be ready.\u003cbr data-start=\"1632\" data-end=\"1635\"\u003e📋 \u003cstrong data-start=\"1638\" data-end=\"1677\"\u003eOperational Checklists \u0026amp; Templates:\u003c\/strong\u003e audit checklists for HPLC, GC, Empower, LIMS, ELN, data review, QC self-assessment, plus templates for DIRA and Audit Trail Review.\u003c\/p\u003e\n\u003cp data-start=\"1811\" data-end=\"1966\"\u003ePerfect for QA Managers, QC Analysts, Supervisors, Data Reviewers, Validation\/CSV Specialists and anyone aiming to build a truly audit-ready QC laboratory.\u003c\/p\u003e\n\u003cp data-start=\"1968\" data-end=\"2071\"\u003e\u003cstrong data-start=\"1968\" data-end=\"1979\"\u003eFormat:\u003c\/strong\u003e Professional PDF\u003cbr data-start=\"1996\" data-end=\"1999\"\u003e\u003cstrong data-start=\"1999\" data-end=\"2009\"\u003ePages:\u003c\/strong\u003e 137\u003cbr data-start=\"2013\" data-end=\"2016\"\u003e\u003cstrong data-start=\"2016\" data-end=\"2028\"\u003eUpdated:\u003c\/strong\u003e December 2025\u003cbr data-start=\"2042\" data-end=\"2045\"\u003e\u003cstrong data-start=\"2045\" data-end=\"2059\"\u003eLanguages:\u003c\/strong\u003e ITA – ENG\u003c\/p\u003e\n\u003cp data-start=\"2073\" data-end=\"2108\"\u003e\u003cstrong data-start=\"2073\" data-end=\"2108\"\u003eDOWNLOAD A PREVIEW OF THE GUIDE\u003c\/strong\u003e\u003c\/p\u003e\n\u003ctable class=\"MsoTableGrid\" border=\"1\" cellspacing=\"0\" cellpadding=\"0\" width=\"54%\" style=\"width: 54.1%; border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt;\"\u003e\n\u003ctbody\u003e\n\u003ctr style=\"mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes;\"\u003e\n\u003ctd width=\"48%\" valign=\"top\" style=\"width: 48.2%; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\"\u003e\n\u003cp class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 115%; text-align: center;\"\u003e\u003ca rel=\"noopener\" title=\"ALCOA+ \u0026amp; Data Governance – La Guida Operativa Definitiva per la Data Integrity Pharma\" href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/ALCOA_Data_Governance_PREVIEW_ITA.pdf?v=1764867342\" target=\"_blank\"\u003e\u003cb\u003ePreview ITA \u003c\/b\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd width=\"50%\" valign=\"top\" style=\"width: 50.9%; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\"\u003e\n\u003cp class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 115%; text-align: center;\"\u003e\u003ca rel=\"noopener\" title=\"ALCOA+ \u0026amp; Data Governance – La Guida Operativa Definitiva per la Data Integrity Pharma\" href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/ALCOA_operational_Guide_to_Data_Integrity_ENG_PREVIEW.pdf?v=1764867387\" target=\"_blank\"\u003e\u003cb\u003ePreview ENG\u0026nbsp;\u003c\/b\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e","brand":"GuideGxP","offers":[{"title":"ENG - English","offer_id":53516862062922,"sku":null,"price":49.0,"currency_code":"EUR","in_stock":true},{"title":"ITA- Italiano","offer_id":53516862095690,"sku":null,"price":49.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/Guide_Operational_Guide_Data_Integrity_in_QC_Laboratories_ENG_COVER.png?v=1764868507"},{"product_id":"usp-382-guida-all-implementazione-per-sistemi-di-chiusura-parenterali","title":"USP 382 – Implementation Guide for Parenteral Closure Systems","description":"\u003cp data-start=\"67\" data-end=\"298\"\u003eUSP \u0026lt;382\u0026gt; introduces a new approach to the qualification of elastomeric components for parenteral products, focusing on the \u003cstrong data-start=\"191\" data-end=\"254\"\u003efunctional suitability of the packaging and delivery system\u003c\/strong\u003e, rather than solely on material compliance.\u003c\/p\u003e\n\u003cp data-start=\"300\" data-end=\"535\"\u003eThis \u003cstrong data-start=\"305\" data-end=\"339\"\u003epractical implementation guide\u003c\/strong\u003e clearly explains how to interpret and apply \u003cstrong data-start=\"384\" data-end=\"397\"\u003eUSP \u0026lt;382\u0026gt;\u003c\/strong\u003e, integrating it with \u003cstrong data-start=\"419\" data-end=\"432\"\u003eUSP \u0026lt;381\u0026gt;\u003c\/strong\u003e and \u003cstrong data-start=\"437\" data-end=\"451\"\u003eUSP \u0026lt;1382\u0026gt;\u003c\/strong\u003e, and translating regulatory requirements into \u003cstrong data-start=\"498\" data-end=\"534\"\u003econcrete, audit-ready activities\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-start=\"537\" data-end=\"771\"\u003eBeyond regulatory interpretation, the guide includes \u003cstrong data-start=\"590\" data-end=\"667\"\u003estructured processes, operational checklists, and real-world case studies\u003c\/strong\u003e, enabling immediate application of the requirements and confident management of audits and inspections.\u003c\/p\u003e\n\u003cp data-start=\"773\" data-end=\"803\"\u003e\u003cstrong data-start=\"773\" data-end=\"803\"\u003eWhat you will find inside:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"805\" data-end=\"1164\"\u003e📘 USP \u0026lt;382\u0026gt; requirements explained in an operational way\u003cbr data-start=\"862\" data-end=\"865\"\u003e✅ Step-by-step functional qualification process\u003cbr data-start=\"912\" data-end=\"915\"\u003e🧪 Practical guidance on key tests (integrity, fragmentation, penetration, self-sealing, plungers, and spikes)\u003cbr data-start=\"1025\" data-end=\"1028\"\u003e📋 Checklists, templates, and scientifically justified acceptance criteria\u003cbr data-start=\"1102\" data-end=\"1105\"\u003e⚠️ Common pitfalls and how to prevent inspection findings\u003c\/p\u003e\n\u003cp data-start=\"1166\" data-end=\"1316\"\u003eA \u003cstrong data-start=\"1168\" data-end=\"1186\"\u003ehands-on guide\u003c\/strong\u003e designed for \u003cstrong data-start=\"1200\" data-end=\"1269\"\u003eQA, QC, Regulatory Affairs, Packaging Development, and Validation\u003c\/strong\u003e professionals involved in injectable products.\u003c\/p\u003e\n\u003cp data-start=\"1318\" data-end=\"1426\"\u003e\u003cstrong data-start=\"1318\" data-end=\"1329\"\u003eFormat:\u003c\/strong\u003e Professional PDF\u003cbr data-start=\"1346\" data-end=\"1349\"\u003e\u003cstrong data-start=\"1349\" data-end=\"1360\"\u003eLength:\u003c\/strong\u003e 71 pages\u003cbr data-start=\"1369\" data-end=\"1372\"\u003e\u003cstrong data-start=\"1372\" data-end=\"1384\"\u003eUpdated:\u003c\/strong\u003e January 2026\u003cbr data-start=\"1397\" data-end=\"1400\"\u003e\u003cstrong data-start=\"1400\" data-end=\"1414\"\u003eLanguages:\u003c\/strong\u003e ITA – ENG\u003c\/p\u003e\n\u003cp data-start=\"1428\" data-end=\"1539\"\u003e\u003cstrong data-start=\"1428\" data-end=\"1463\"\u003eDOWNLOAD A PREVIEW OF THE GUIDE\u003c\/strong\u003e\u003c\/p\u003e\n\u003ctable class=\"MsoTableGrid\" border=\"1\" cellspacing=\"0\" cellpadding=\"0\" width=\"54%\" style=\"width: 54.1%; border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt;\"\u003e\n\u003ctbody\u003e\n\u003ctr style=\"mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes;\"\u003e\n\u003ctd width=\"48%\" valign=\"top\" style=\"width: 48.2%; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\"\u003e\n\u003cp class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 115%; text-align: center;\"\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/USP_382_guida_all_implementazione_per_sistemi_di_chiusura_parenterali_ITA_PREVIEW.pdf?v=1766308660\" rel=\"noopener\" target=\"_blank\"\u003e\u003cb\u003ePreview ITA \u003c\/b\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd width=\"50%\" valign=\"top\" style=\"width: 50.9%; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\"\u003e\n\u003cp class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 115%; text-align: center;\"\u003e\u003cb\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/USP_382_Implementation_Guide_for_Parenteral_Closure_Systems_ENG_PREVIEW.pdf?v=1766308617\" rel=\"noopener\" target=\"_blank\"\u003ePreview ENG\u0026nbsp;\u003c\/a\u003e\u003ca rel=\"noopener\" title=\"ALCOA+ \u0026amp; Data Governance – La Guida Operativa Definitiva per la Data Integrity Pharma\" href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/ALCOA_operational_Guide_to_Data_Integrity_ENG_PREVIEW.pdf?v=1764867387\" target=\"_blank\"\u003e\u003c\/a\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e","brand":"GuideGxP","offers":[{"title":"ENG - English","offer_id":53636267213130,"sku":null,"price":199.0,"currency_code":"EUR","in_stock":true},{"title":"ITA- Italiano","offer_id":53636267245898,"sku":null,"price":199.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/USP_382_Implemetation_guide_for_parenteral_closure_systems_COVER_1e341aed-2baa-499b-896b-1fd0afddc0fc.png?v=1766308768"},{"product_id":"farmacopee-a-confronto-gmp-gestione-divergenze","title":"GMP Pharmacopoeias Compared: Operational Management of USP – Ph. Eur. – JP – BP Divergences in GxP Audits","description":"\u003cp data-start=\"117\" data-end=\"408\"\u003eWhen a product is intended for multiple markets, compliance with a single pharmacopoeia is not enough.\u003cbr data-start=\"219\" data-end=\"222\"\u003eDuring EMA, FDA, or PIC\/S audits, the most costly observations almost always arise from poorly managed compendial divergences: missing tests, inconsistent limits, non-defensible methods.\u003c\/p\u003e\n\u003cp data-start=\"410\" data-end=\"716\"\u003eThis guide is designed for professionals who don’t have time to study four pharmacopoeias, but must make fast, correct, and defensible decisions.\u0026nbsp;It is written for QA, QC, QP, and Regulatory Managers working in multi-market environments who want to reduce audit risk without duplicating unnecessary work.\u003c\/p\u003e\n\u003ch3 data-start=\"723\" data-end=\"764\"\u003eThe Real Problem (No One Talks About)\u003c\/h3\u003e\n\u003cp data-start=\"766\" data-end=\"806\"\u003eIn daily practice, this is what happens:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"810\" data-end=\"874\"\u003eUSP and Ph. Eur. require the same thing, but in different ways\u003c\/li\u003e\n\u003cli data-start=\"877\" data-end=\"952\"\u003eSome tests are harmonized, others are not—and no one clearly states which\u003c\/li\u003e\n\u003cli data-start=\"955\" data-end=\"1013\"\u003eA method is accepted in the EU but challenged by the FDA\u003c\/li\u003e\n\u003cli data-start=\"1016\" data-end=\"1074\"\u003eLimits do not match, and it’s unclear which one to apply\u003c\/li\u003e\n\u003cli data-start=\"1077\" data-end=\"1146\"\u003eDocuments are rewritten multiple times after avoidable observations\u003c\/li\u003e\n\u003cli data-start=\"1149\" data-end=\"1242\"\u003eDuring audits, you must defend decisions made years earlier, without a structured rationale\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1244\" data-end=\"1321\"\u003e\u003cstrong data-start=\"1244\" data-end=\"1259\"\u003eThe result:\u003c\/strong\u003e wasted time, stress, rework, and unnecessary regulatory risk.\u003c\/p\u003e\n\u003ch3 data-start=\"1328\" data-end=\"1361\"\u003eThe Concrete Benefits You Get\u003c\/h3\u003e\n\u003cp data-start=\"1363\" data-end=\"1392\"\u003eWith this guide, you achieve:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"1396\" data-end=\"1459\"\u003eFaster decisions on which tests to perform (and which not to)\u003c\/li\u003e\n\u003cli data-start=\"1462\" data-end=\"1507\"\u003eA drastic reduction in GMP observation risk\u003c\/li\u003e\n\u003cli data-start=\"1510\" data-end=\"1575\"\u003eUnified specifications based on the most defensible requirement\u003c\/li\u003e\n\u003cli data-start=\"1578\" data-end=\"1644\"\u003eRationalized analytical methods, without unnecessary duplication\u003c\/li\u003e\n\u003cli data-start=\"1647\" data-end=\"1701\"\u003eGreater confidence during FDA, EMA, and PIC\/S audits\u003c\/li\u003e\n\u003cli data-start=\"1704\" data-end=\"1782\"\u003eWeeks of work saved by avoiding manual, line-by-line comparison of standards\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1784\" data-end=\"1846\"\u003eNo theory. Only operational choices you can apply immediately.\u003c\/p\u003e\n\u003ch3 data-start=\"1853\" data-end=\"1887\"\u003eWhat the Guide Really Contains\u003c\/h3\u003e\n\u003cp data-start=\"1889\" data-end=\"2007\"\u003eThis is \u003cstrong data-start=\"1897\" data-end=\"1904\"\u003enot\u003c\/strong\u003e an explanation of pharmacopoeias.\u003cbr data-start=\"1938\" data-end=\"1941\"\u003eIt is an \u003cstrong data-start=\"1950\" data-end=\"1972\"\u003eoperational manual\u003c\/strong\u003e for using them together—correctly.\u003c\/p\u003e\n\u003cp data-start=\"2009\" data-end=\"2029\"\u003eInside, you’ll find:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"2033\" data-end=\"2092\"\u003eStructured comparison: \u003cstrong data-start=\"2056\" data-end=\"2090\"\u003eUSP vs. Ph. Eur. vs. JP vs. BP\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli data-start=\"2095\" data-end=\"2117\"\u003eClear tables covering:\n\u003cul\u003e\n\u003cli data-start=\"2122\" data-end=\"2135\"\u003eDissolution\u003c\/li\u003e\n\u003cli data-start=\"2140\" data-end=\"2156\"\u003eDisintegration\u003c\/li\u003e\n\u003cli data-start=\"2161\" data-end=\"2189\"\u003eUniformity of dosage units\u003c\/li\u003e\n\u003cli data-start=\"2194\" data-end=\"2206\"\u003eImpurities\u003c\/li\u003e\n\u003cli data-start=\"2211\" data-end=\"2218\"\u003eAssay\u003c\/li\u003e\n\u003cli data-start=\"2223\" data-end=\"2260\"\u003eEndotoxins, sterility, particulates\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2263\" data-end=\"2311\"\u003eWhat is truly harmonized (PDG) and what is not\u003c\/li\u003e\n\u003cli data-start=\"2314\" data-end=\"2367\"\u003eWhen a single method can be used—and when it cannot\u003c\/li\u003e\n\u003cli data-start=\"2370\" data-end=\"2423\"\u003eHow to choose the correct limit when values diverge\u003c\/li\u003e\n\u003cli data-start=\"2426\" data-end=\"2483\"\u003eMulti-compendial testing strategies without duplication\u003c\/li\u003e\n\u003cli data-start=\"2486\" data-end=\"2555\"\u003eCriteria for using alternative methods and defending them in audits\u003c\/li\u003e\n\u003cli data-start=\"2558\" data-end=\"2614\"\u003eReady-to-use operational checklists and decision flows\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2616\" data-end=\"2711\"\u003eEach section answers one question only:\u003cbr data-start=\"2655\" data-end=\"2658\"\u003e\u003cstrong data-start=\"2658\" data-end=\"2711\"\u003e“What do I actually do, tomorrow, in my company?”\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"2718\" data-end=\"2740\"\u003eWhy Buy This Guide\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli data-start=\"2744\" data-end=\"2779\"\u003eStandards are already interpreted\u003c\/li\u003e\n\u003cli data-start=\"2782\" data-end=\"2816\"\u003eAmbiguities are already resolved\u003c\/li\u003e\n\u003cli data-start=\"2819\" data-end=\"2850\"\u003eCritical decisions are guided\u003c\/li\u003e\n\u003cli data-start=\"2853\" data-end=\"2902\"\u003eYou don’t have to start from scratch every time\u003c\/li\u003e\n\u003cli data-start=\"2905\" data-end=\"2948\"\u003eYou avoid errors that cost days of rework\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2950\" data-end=\"3105\"\u003eThis guide is based on real international GMP audit experience\u003cbr data-start=\"3012\" data-end=\"3015\"\u003eand written by professionals who have defended technical decisions in front of inspectors.\u003c\/p\u003e\n\u003ch3 data-start=\"3112\" data-end=\"3131\"\u003eProduct Details\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli data-start=\"3135\" data-end=\"3165\"\u003e\u003cstrong data-start=\"3135\" data-end=\"3146\"\u003eFormat:\u003c\/strong\u003e Professional PDF\u003c\/li\u003e\n\u003cli data-start=\"3168\" data-end=\"3191\"\u003e\u003cstrong data-start=\"3168\" data-end=\"3179\"\u003eLength:\u003c\/strong\u003e 101 pages\u003c\/li\u003e\n\u003cli data-start=\"3194\" data-end=\"3222\"\u003e\u003cstrong data-start=\"3194\" data-end=\"3206\"\u003eUpdated:\u003c\/strong\u003e February 2026\u003c\/li\u003e\n\u003cli data-start=\"3225\" data-end=\"3251\"\u003e\u003cstrong data-start=\"3225\" data-end=\"3239\"\u003eLanguages:\u003c\/strong\u003e ITA – ENG\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3253\" data-end=\"3288\"\u003e\u003cstrong data-start=\"3253\" data-end=\"3288\"\u003eDOWNLOAD A PREVIEW OF THE GUIDE\u003c\/strong\u003e\u003c\/p\u003e\n\u003ctable class=\"MsoTableGrid\" border=\"1\" cellspacing=\"0\" cellpadding=\"0\" width=\"54%\" style=\"width: 54.1%; border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt;\"\u003e\n\u003ctbody\u003e\n\u003ctr style=\"mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes;\"\u003e\n\u003ctd width=\"48%\" valign=\"top\" style=\"width: 48.2%; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\"\u003e\n\u003cp class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 115%; text-align: center;\"\u003e\u003ca rel=\"noopener\" href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/Farmacopee_a_Confronto_come_risolvere_le_divergenze_USPPh._Eur._PREVIEW.pdf?v=1770479434\" target=\"_blank\"\u003e\u003cb\u003ePreview ITA \u003c\/b\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd width=\"50%\" valign=\"top\" style=\"width: 50.9%; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\"\u003e\n\u003cp class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 115%; text-align: center;\"\u003e\u003cb\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/ISO_14644-5_2025_Operational_Guide_to_Cleanroom_Operations.pdf?v=1768659505\" target=\"_blank\"\u003e\u003c\/a\u003e\u003ca rel=\"noopener\" href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/Comparison_of_Pharmacopeias_How_to_Resolve_USP_Ph_Eur_Divergences_PREVIEW.pdf?v=1770479464\" target=\"_blank\"\u003ePreview ENG\u003c\/a\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/ISO_14644-5_2025_Operational_Guide_to_Cleanroom_Operations.pdf?v=1768659505\" target=\"_blank\"\u003e\u0026nbsp;\u003c\/a\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/Operational_Guide_to_GMP_Cleaning_Validation_ENG_PREVIEW.pdf?v=1766920760\" rel=\"noopener\" target=\"_blank\"\u003e\u003c\/a\u003e\u003ca rel=\"noopener\" title=\"ALCOA+ \u0026amp; Data Governance – La Guida Operativa Definitiva per la Data Integrity Pharma\" href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/ALCOA_operational_Guide_to_Data_Integrity_ENG_PREVIEW.pdf?v=1764867387\" target=\"_blank\"\u003e\u003c\/a\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e","brand":"GuideGxP","offers":[{"title":"ENG - English","offer_id":61043563659594,"sku":null,"price":149.0,"currency_code":"EUR","in_stock":true},{"title":"ITA- Italiano","offer_id":61043563692362,"sku":null,"price":149.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/Comparing_pharmacopeia_USP_PH_EUR_COVER.png?v=1770479290"},{"product_id":"standard-di-riferimento-qc-nelle-farmacopee-gestione-gmp-tra-usp-e-ph-eur","title":"QC Reference Standards in Pharmacopoeias: GMP Management Between USP and Ph. Eur.","description":"\u003cp data-start=\"220\" data-end=\"617\"\u003eThe management of Reference Standards is one of the most underestimated — and most frequently challenged — areas during GMP inspections.\u003cbr data-start=\"356\" data-end=\"359\"\u003eUSP, Ph. Eur. and GMP requirements are clear on \u003cem data-start=\"407\" data-end=\"413\"\u003ewhat\u003c\/em\u003e must be used, but they do not explain \u003cstrong data-start=\"452\" data-end=\"500\"\u003ehow to make defensible operational decisions\u003c\/strong\u003e when you need to qualify a standard, extend its validity, use it outside a monograph, or justify it to an inspector.\u003c\/p\u003e\n\u003cp data-start=\"619\" data-end=\"930\"\u003eThis guide is built on real EMA and FDA audit experience and translates fragmented requirements into \u003cstrong data-start=\"720\" data-end=\"782\"\u003epractical, documented, and inspection-defensible decisions\u003c\/strong\u003e.\u003cbr data-start=\"783\" data-end=\"786\"\u003eIt is designed for QC, QA and laboratory professionals who work under audit pressure, have limited time, and cannot afford weak interpretations.\u003c\/p\u003e\n\u003ch2 data-start=\"937\" data-end=\"966\"\u003e\u003cstrong data-start=\"940\" data-end=\"966\"\u003eThe Real-World Problem\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-start=\"968\" data-end=\"1025\"\u003eIn day-to-day operations, this is what typically happens:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"1029\" data-end=\"1101\"\u003ePharmacopoeias state \u003cstrong data-start=\"1050\" data-end=\"1065\"\u003ewhat to use\u003c\/strong\u003e, but not \u003cstrong data-start=\"1075\" data-end=\"1101\"\u003ehow to truly manage it\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli data-start=\"1104\" data-end=\"1192\"\u003eEach auditor applies a different interpretation of primary, secondary standards and CRMs\u003c\/li\u003e\n\u003cli data-start=\"1195\" data-end=\"1267\"\u003eStandards are used for years without a defined re-qualification strategy\u003c\/li\u003e\n\u003cli data-start=\"1270\" data-end=\"1321\"\u003eSOPs exist but collapse under inspector questioning\u003c\/li\u003e\n\u003cli data-start=\"1324\" data-end=\"1396\"\u003eAudits raise doubts on traceability, assay values, and off-monograph use\u003c\/li\u003e\n\u003cli data-start=\"1399\" data-end=\"1482\"\u003eDocuments are rewritten multiple times, explanations become defensive, time is lost\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1484\" data-end=\"1559\"\u003e\u003cstrong data-start=\"1484\" data-end=\"1499\"\u003eThe result?\u003c\/strong\u003e Uncertainty, rework, and avoidable inspection observations.\u003c\/p\u003e\n\u003ch2 data-start=\"1566\" data-end=\"1601\"\u003e\u003cstrong data-start=\"1569\" data-end=\"1601\"\u003eThe Concrete Benefit You Get\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-start=\"1603\" data-end=\"1629\"\u003eWith this guide, you gain:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"1633\" data-end=\"1710\"\u003eFast, well-justified decisions on primary, secondary standards and impurities\u003c\/li\u003e\n\u003cli data-start=\"1713\" data-end=\"1758\"\u003eA drastic reduction in audit preparation time\u003c\/li\u003e\n\u003cli data-start=\"1761\" data-end=\"1833\"\u003eClear criteria for qualification, re-qualification and expiry management\u003c\/li\u003e\n\u003cli data-start=\"1836\" data-end=\"1905\"\u003eGreater confidence when defending decisions to EMA and FDA inspectors\u003c\/li\u003e\n\u003cli data-start=\"1908\" data-end=\"1970\"\u003eFewer deviations, fewer “unexplained” OOS results, less rework\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1972\" data-end=\"2022\"\u003eNo theory. \u003cstrong data-start=\"1983\" data-end=\"2022\"\u003eReady-to-use operational decisions.\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch2 data-start=\"2029\" data-end=\"2066\"\u003e\u003cstrong data-start=\"2032\" data-end=\"2066\"\u003eWhat the Guide Really Contains\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-start=\"2068\" data-end=\"2109\"\u003eImmediately usable, field-tested content:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"2113\" data-end=\"2172\"\u003eA complete GMP management framework for Reference Standards\u003c\/li\u003e\n\u003cli data-start=\"2175\" data-end=\"2231\"\u003eOperational differences between USP, Ph. Eur., JP and BP\u003c\/li\u003e\n\u003cli data-start=\"2234\" data-end=\"2257\"\u003ePractical criteria for:\n\u003cul\u003e\n\u003cli data-start=\"2262\" data-end=\"2294\"\u003eSecondary standard qualification\u003c\/li\u003e\n\u003cli data-start=\"2299\" data-end=\"2306\"\u003eCRM use\u003c\/li\u003e\n\u003cli data-start=\"2311\" data-end=\"2329\"\u003eValidity extension\u003c\/li\u003e\n\u003cli data-start=\"2334\" data-end=\"2351\"\u003eOff-monograph use\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2354\" data-end=\"2390\"\u003eAudit-ready checklists for QC and QA\u003c\/li\u003e\n\u003cli data-start=\"2393\" data-end=\"2407\"\u003eTemplates for:\n\u003cul\u003e\n\u003cli data-start=\"2412\" data-end=\"2430\"\u003eStandard inventory\u003c\/li\u003e\n\u003cli data-start=\"2435\" data-end=\"2444\"\u003eUsage log\u003c\/li\u003e\n\u003cli data-start=\"2449\" data-end=\"2488\"\u003eInternal secondary standard certificate\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2491\" data-end=\"2532\"\u003eReal audit findings and how to avoid them\u003c\/li\u003e\n\u003cli data-start=\"2535\" data-end=\"2586\"\u003ePractical examples and typical inspection scenarios\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2588\" data-end=\"2631\"\u003eA \u003cstrong data-start=\"2590\" data-end=\"2604\"\u003edesk guide\u003c\/strong\u003e, not a bookshelf document.\u003c\/p\u003e\n\u003ch2 data-start=\"2638\" data-end=\"2663\"\u003e\u003cstrong data-start=\"2641\" data-end=\"2663\"\u003eWhy Buy This Guide\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-start=\"2665\" data-end=\"2715\"\u003eBecause it does the work that normally takes days:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"2719\" data-end=\"2755\"\u003eRequirements are already interpreted\u003c\/li\u003e\n\u003cli data-start=\"2758\" data-end=\"2790\"\u003eDecisions are already structured\u003c\/li\u003e\n\u003cli data-start=\"2793\" data-end=\"2819\"\u003eRisks are already assessed\u003c\/li\u003e\n\u003cli data-start=\"2822\" data-end=\"2865\"\u003eInspection justifications are already built\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-start=\"2872\" data-end=\"2927\"\u003e\u003cstrong data-start=\"2875\" data-end=\"2927\"\u003eWho This Guide Is Really For (and Who It Is Not)\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-start=\"2929\" data-end=\"2945\"\u003e✅ \u003cstrong data-start=\"2931\" data-end=\"2945\"\u003eIdeal for:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"2948\" data-end=\"2961\"\u003eQC Analysts\u003c\/li\u003e\n\u003cli data-start=\"2964\" data-end=\"2988\"\u003eLaboratory Supervisors\u003c\/li\u003e\n\u003cli data-start=\"2991\" data-end=\"3006\"\u003eLaboratory QA\u003c\/li\u003e\n\u003cli data-start=\"3009\" data-end=\"3028\"\u003eQC \/ Lab Managers\u003c\/li\u003e\n\u003cli data-start=\"3031\" data-end=\"3058\"\u003eMetrology and Calibration\u003c\/li\u003e\n\u003cli data-start=\"3061\" data-end=\"3102\"\u003eRegulatory Affairs involved in dossiers\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3104\" data-end=\"3127\"\u003e❌ \u003cstrong data-start=\"3106\" data-end=\"3127\"\u003eNot suitable for:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"3130\" data-end=\"3179\"\u003eThose looking for an introductory GMP explanation\u003c\/li\u003e\n\u003cli data-start=\"3182\" data-end=\"3208\"\u003eNon-regulated environments\u003c\/li\u003e\n\u003cli data-start=\"3211\" data-end=\"3265\"\u003eRoles without operational or inspection responsibility\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3267\" data-end=\"3517\"\u003eThis guide is written by professionals who have \u003cstrong data-start=\"3315\" data-end=\"3347\"\u003eactually answered inspectors\u003c\/strong\u003e, not by those who merely comment on regulations.\u003cbr data-start=\"3396\" data-end=\"3399\"\u003eIt aligns with EMA, FDA and GMP expectations and is designed to be \u003cstrong data-start=\"3466\" data-end=\"3516\"\u003eaudit-ready from the first to the last chapter\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-start=\"3519\" data-end=\"3612\"\u003eIf you work in QC\/QA, this guide is \u003cstrong data-start=\"3555\" data-end=\"3571\"\u003enot optional\u003c\/strong\u003e.\u003cbr data-start=\"3572\" data-end=\"3575\"\u003eIt is an \u003cstrong data-start=\"3584\" data-end=\"3611\"\u003eoperational accelerator\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch2 data-start=\"3619\" data-end=\"3641\"\u003e\u003cstrong data-start=\"3622\" data-end=\"3641\"\u003eProduct Details\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli data-start=\"3645\" data-end=\"3675\"\u003e\u003cstrong data-start=\"3645\" data-end=\"3656\"\u003eFormat:\u003c\/strong\u003e Professional PDF\u003c\/li\u003e\n\u003cli data-start=\"3678\" data-end=\"3700\"\u003e\u003cstrong data-start=\"3678\" data-end=\"3689\"\u003eLength:\u003c\/strong\u003e 62 pages\u003c\/li\u003e\n\u003cli data-start=\"3703\" data-end=\"3730\"\u003e\u003cstrong data-start=\"3703\" data-end=\"3715\"\u003eUpdated:\u003c\/strong\u003e January 2026\u003c\/li\u003e\n\u003cli data-start=\"3733\" data-end=\"3759\"\u003e\u003cstrong data-start=\"3733\" data-end=\"3747\"\u003eLanguages:\u003c\/strong\u003e ITA – ENG\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3761\" data-end=\"3796\"\u003e\u003cstrong data-start=\"3761\" data-end=\"3796\"\u003eDOWNLOAD A PREVIEW OF THE GUIDE\u003c\/strong\u003e\u003c\/p\u003e\n\u003ctable class=\"MsoTableGrid\" border=\"1\" cellspacing=\"0\" cellpadding=\"0\" width=\"54%\" style=\"width: 54.1%; border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt;\"\u003e\n\u003ctbody\u003e\n\u003ctr style=\"mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes;\"\u003e\n\u003ctd width=\"48%\" valign=\"top\" style=\"width: 48.2%; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\"\u003e\n\u003cp class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 115%; text-align: center;\"\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/Standard_di_Riferimento_e_Strumentazione_QC_Gestione_GMP_tra_requi.pdf?v=1770490849\" rel=\"noopener\" target=\"_blank\"\u003e\u003cb\u003ePreview ITA \u003c\/b\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd width=\"50%\" valign=\"top\" style=\"width: 50.9%; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\"\u003e\n\u003cp class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 115%; text-align: center;\"\u003e\u003cb\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/Reference_Standards_and_QC_Instrumentation_GMP_Management_Between_USP_Ph._Eur._PREVIEW.pdf?v=1770490926\" rel=\"noopener\" target=\"_blank\"\u003ePreview ENG\u0026nbsp;\u003c\/a\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/ISO_14644-5_2025_Operational_Guide_to_Cleanroom_Operations.pdf?v=1768659505\" target=\"_blank\"\u003e\u003c\/a\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/Operational_Guide_to_GMP_Cleaning_Validation_ENG_PREVIEW.pdf?v=1766920760\" rel=\"noopener\" target=\"_blank\"\u003e\u003c\/a\u003e\u003ca rel=\"noopener\" title=\"ALCOA+ \u0026amp; Data Governance – La Guida Operativa Definitiva per la Data Integrity Pharma\" href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/ALCOA_operational_Guide_to_Data_Integrity_ENG_PREVIEW.pdf?v=1764867387\" target=\"_blank\"\u003e\u003c\/a\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e","brand":"GuideGxP","offers":[{"title":"ENG - English","offer_id":61044315357514,"sku":null,"price":149.0,"currency_code":"EUR","in_stock":true},{"title":"ITA- Italiano","offer_id":61044315390282,"sku":null,"price":149.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/Reference_standards_QC_USP_PH_EUR_COVER.png?v=1770490603"},{"product_id":"test-dissoluzione-metodi-compendiali-gmp","title":"Dissolution Testing and Compendial Methods in GMP Pharmacopeias – Audit-Ready Operational Guide (USP, Ph. Eur.)","description":"\u003cp data-start=\"240\" data-end=\"549\"\u003eDissolution testing is one of the most exposed topics during GMP audits.\u003cbr data-start=\"312\" data-end=\"315\"\u003eIt is technically complex, highly variable, and often poorly understood—even in experienced laboratories.\u003cbr data-start=\"420\" data-end=\"423\"\u003eFollowing USP or Ph. Eur. “by the book” is not enough: inspectors expect control, conscious choices, and defensible decisions.\u003c\/p\u003e\n\u003cp data-start=\"551\" data-end=\"775\"\u003eThis guide is designed for QC, QA, and QPs working under audit pressure who must take fast, well-reasoned decisions—without getting lost in pharmacopeial chapters, ambiguous interpretations, or repeatedly reworked documents.\u003c\/p\u003e\n\u003cp data-start=\"777\" data-end=\"914\"\u003eIt does not explain \u003cstrong data-start=\"797\" data-end=\"825\"\u003ewhat the regulation says\u003c\/strong\u003e.\u003cbr data-start=\"826\" data-end=\"829\"\u003eIt tells you \u003cstrong data-start=\"842\" data-end=\"913\"\u003ewhat to do, how to do it, and how to defend it during an inspection\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch2 data-start=\"921\" data-end=\"941\"\u003eThe Real Problem\u003c\/h2\u003e\n\u003cp data-start=\"943\" data-end=\"983\"\u003eIn daily practice, this is what happens:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"987\" data-end=\"1043\"\u003eUSP and Ph. Eur. say similar things… but not identical\u003c\/li\u003e\n\u003cli data-start=\"1046\" data-end=\"1128\"\u003eMethods are “compendial”, yet no one clearly defines how far they can be adapted\u003c\/li\u003e\n\u003cli data-start=\"1131\" data-end=\"1193\"\u003eS1–S2–S3 criteria are known, but poorly managed under stress\u003c\/li\u003e\n\u003cli data-start=\"1196\" data-end=\"1258\"\u003eA dissolution OOS immediately becomes a regulatory time bomb\u003c\/li\u003e\n\u003cli data-start=\"1261\" data-end=\"1326\"\u003eEach laboratory applies the method “as it has always been done”\u003c\/li\u003e\n\u003cli data-start=\"1329\" data-end=\"1398\"\u003eIn an audit, however, every choice must be explained and documented\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1400\" data-end=\"1525\"\u003e\u003cstrong data-start=\"1400\" data-end=\"1415\"\u003eThe result?\u003c\/strong\u003e\u003cbr data-start=\"1415\" data-end=\"1418\"\u003eSlow decisions, uncertainty in front of the inspector, weak investigations, and days of unnecessary rework.\u003c\/p\u003e\n\u003ch2 data-start=\"1532\" data-end=\"1564\"\u003eThe Concrete Benefit You Get\u003c\/h2\u003e\n\u003cp data-start=\"1566\" data-end=\"1591\"\u003eWith this guide you will:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"1595\" data-end=\"1638\"\u003eDrastically reduce audit preparation time\u003c\/li\u003e\n\u003cli data-start=\"1641\" data-end=\"1699\"\u003eKnow when a failure is truly an OOS (and when it is not)\u003c\/li\u003e\n\u003cli data-start=\"1702\" data-end=\"1750\"\u003eAvoid errors that lead to avoidable deviations\u003c\/li\u003e\n\u003cli data-start=\"1753\" data-end=\"1796\"\u003eManage USP and Ph. Eur. without confusion\u003c\/li\u003e\n\u003cli data-start=\"1799\" data-end=\"1857\"\u003eDefend your decisions using inspection logic, not theory\u003c\/li\u003e\n\u003cli data-start=\"1860\" data-end=\"1912\"\u003eFace audits with confidence, not in defensive mode\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1914\" data-end=\"1993\"\u003eEach chapter is designed to \u003cstrong data-start=\"1942\" data-end=\"1966\"\u003eaccelerate decisions\u003c\/strong\u003e, not to study regulations.\u003c\/p\u003e\n\u003ch2 data-start=\"2000\" data-end=\"2027\"\u003eWhat the Guide Contains\u003c\/h2\u003e\n\u003cp data-start=\"2029\" data-end=\"2073\"\u003eImmediately usable, not descriptive content:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"2077\" data-end=\"2125\"\u003ePractical interpretation of compendial methods\u003c\/li\u003e\n\u003cli data-start=\"2128\" data-end=\"2172\"\u003eOperational comparison of USP vs. Ph. Eur.\u003c\/li\u003e\n\u003cli data-start=\"2175\" data-end=\"2238\"\u003eClear explanation of S1, S2, S3 criteria (with real examples)\u003c\/li\u003e\n\u003cli data-start=\"2241\" data-end=\"2269\"\u003eAudit-ready management of:\n\u003cul\u003e\n\u003cli data-start=\"2274\" data-end=\"2285\"\u003eApparatus\u003c\/li\u003e\n\u003cli data-start=\"2290\" data-end=\"2298\"\u003eMedium\u003c\/li\u003e\n\u003cli data-start=\"2303\" data-end=\"2314\"\u003eDegassing\u003c\/li\u003e\n\u003cli data-start=\"2319\" data-end=\"2328\"\u003eFilters\u003c\/li\u003e\n\u003cli data-start=\"2333\" data-end=\"2343\"\u003eSampling\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2346\" data-end=\"2400\"\u003eOOS and deviation management for dissolution testing\u003c\/li\u003e\n\u003cli data-start=\"2403\" data-end=\"2457\"\u003eRisk-based approach for multi-pharmacopeia decisions\u003c\/li\u003e\n\u003cli data-start=\"2460\" data-end=\"2497\"\u003eOperational “Audit-Ready” checklist\u003c\/li\u003e\n\u003cli data-start=\"2500\" data-end=\"2553\"\u003eTypical inspection findings (and how to avoid them)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2555\" data-end=\"2613\"\u003e\u003cstrong data-start=\"2555\" data-end=\"2613\"\u003eNo theory. Operational decisions already made for you.\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch2 data-start=\"2620\" data-end=\"2643\"\u003eWhy Buy This Guide?\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli data-start=\"2647\" data-end=\"2684\"\u003eRegulations are already interpreted\u003c\/li\u003e\n\u003cli data-start=\"2687\" data-end=\"2718\"\u003eCritical decisions are guided\u003c\/li\u003e\n\u003cli data-start=\"2721\" data-end=\"2773\"\u003eYou don’t need to rebuild the reasoning every time\u003c\/li\u003e\n\u003cli data-start=\"2776\" data-end=\"2837\"\u003eYou avoid unnecessary investigations and avoidable findings\u003c\/li\u003e\n\u003cli data-start=\"2840\" data-end=\"2883\"\u003eIt costs less than a single day of rework\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2885\" data-end=\"2937\"\u003eA guide that \u003cstrong data-start=\"2898\" data-end=\"2936\"\u003epays for itself at the first audit\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch2 data-start=\"2944\" data-end=\"2995\"\u003eWho This Guide Is Really For (and Who It’s Not)\u003c\/h2\u003e\n\u003cp data-start=\"2997\" data-end=\"3011\"\u003e\u003cstrong data-start=\"2997\" data-end=\"3011\"\u003eIdeal for:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"3014\" data-end=\"3041\"\u003eQC Analysts \u0026amp; QC Managers\u003c\/li\u003e\n\u003cli data-start=\"3044\" data-end=\"3074\"\u003eQA Specialists \u0026amp; QA Managers\u003c\/li\u003e\n\u003cli data-start=\"3077\" data-end=\"3101\"\u003eQualified Persons (QP)\u003c\/li\u003e\n\u003cli data-start=\"3104\" data-end=\"3155\"\u003eRegulatory Affairs involved in analytical methods\u003c\/li\u003e\n\u003cli data-start=\"3158\" data-end=\"3211\"\u003eLaboratories operating in multi-market environments\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3213\" data-end=\"3225\"\u003e\u003cstrong data-start=\"3213\" data-end=\"3225\"\u003eNot for:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"3228\" data-end=\"3288\"\u003eThose looking for an academic explanation of pharmacopeias\u003c\/li\u003e\n\u003cli data-start=\"3291\" data-end=\"3337\"\u003eRoles without decision-making responsibility\u003c\/li\u003e\n\u003cli data-start=\"3340\" data-end=\"3388\"\u003eProfessionals not working under audit pressure\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3390\" data-end=\"3615\"\u003eThis guide is built on \u003cstrong data-start=\"3413\" data-end=\"3438\"\u003ereal audit experience\u003c\/strong\u003e, not theoretical interpretation.\u003cbr data-start=\"3471\" data-end=\"3474\"\u003eIt is aligned with \u003cstrong data-start=\"3493\" data-end=\"3529\"\u003eEMA, FDA, and PIC\/S expectations\u003c\/strong\u003e and designed to make dissolution testing \u003cstrong data-start=\"3571\" data-end=\"3614\"\u003edefensible, consistent, and audit-ready\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch2 data-start=\"3622\" data-end=\"3641\"\u003eProduct Details\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli data-start=\"3645\" data-end=\"3675\"\u003e\u003cstrong data-start=\"3645\" data-end=\"3656\"\u003eFormat:\u003c\/strong\u003e Professional PDF\u003c\/li\u003e\n\u003cli data-start=\"3678\" data-end=\"3700\"\u003e\u003cstrong data-start=\"3678\" data-end=\"3689\"\u003eLength:\u003c\/strong\u003e 51 pages\u003c\/li\u003e\n\u003cli data-start=\"3703\" data-end=\"3731\"\u003e\u003cstrong data-start=\"3703\" data-end=\"3715\"\u003eUpdated:\u003c\/strong\u003e February 2026\u003c\/li\u003e\n\u003cli data-start=\"3734\" data-end=\"3760\"\u003e\u003cstrong data-start=\"3734\" data-end=\"3748\"\u003eLanguages:\u003c\/strong\u003e ITA – ENG\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3762\" data-end=\"3797\"\u003e\u003cstrong data-start=\"3762\" data-end=\"3797\"\u003eDOWNLOAD A PREVIEW OF THE GUIDE\u003c\/strong\u003e\u003c\/p\u003e\n\u003ctable style=\"width: 54.1%; border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt;\" width=\"54%\" cellpadding=\"0\" cellspacing=\"0\" border=\"1\" class=\"MsoTableGrid\"\u003e\n\u003ctbody\u003e\n\u003ctr style=\"mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes;\"\u003e\n\u003ctd style=\"width: 48.2%; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"48%\"\u003e\n\u003cp style=\"margin-bottom: 8pt; line-height: 115%; text-align: center;\" class=\"MsoNormal\"\u003e\u003ca rel=\"noopener\" href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/Guida_alle_Farmacopee_Test_di_Dissoluzione_e_Metodi_Compendiali_PREVIEW.pdf?v=1770547143\" target=\"_blank\"\u003e\u003cb\u003ePreview ITA \u003c\/b\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd style=\"width: 50.9%; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"50%\"\u003e\n\u003cp style=\"margin-bottom: 8pt; line-height: 115%; text-align: center;\" class=\"MsoNormal\"\u003e\u003ca rel=\"noopener\" href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/Guide_to_Pharmacopoeias_Dissolution_Tests_and_Compendial_Methods_PREVIEW.pdf?v=1770547167\" target=\"_blank\"\u003e\u003cb\u003eP\u003c\/b\u003e\u003cb style=\"font-size: 0.875rem;\"\u003e\u003c\/b\u003e\u003cb style=\"font-size: 0.875rem;\"\u003ereview ENG\u0026nbsp;\u003c\/b\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e","brand":"GuideGxP","offers":[{"title":"ENG - English","offer_id":61046042788170,"sku":null,"price":149.0,"currency_code":"EUR","in_stock":true},{"title":"ITA- Italiano","offer_id":61046042820938,"sku":null,"price":149.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/Pharmacopoeias_dissolution_tests_compendiam_metod_COVER.png?v=1770547029"},{"product_id":"farmacopee-gmp-impurita-saggi-critici-guida-operativa","title":"GMP Pharmacopeias – Impurities and Critical Assays: Operational Multi-Region Management ICH vs USP vs Ph. Eur.","description":"\u003cp data-start=\"212\" data-end=\"467\"\u003eImpurities and biological assays are among the leading causes of critical observations during EMA, FDA, and PIC\/S inspections.\u003cbr data-start=\"338\" data-end=\"341\"\u003eNot because tests are missing, but because the \u003cstrong data-start=\"388\" data-end=\"466\"\u003erationale behind limits, specifications, and analytical choices is missing\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-start=\"469\" data-end=\"640\"\u003eICH guidelines and Pharmacopeias state \u003cem data-start=\"508\" data-end=\"514\"\u003ewhat\u003c\/em\u003e must be done.\u003cbr data-start=\"528\" data-end=\"531\"\u003eDuring an audit, however, inspectors ask \u003cem data-start=\"572\" data-end=\"577\"\u003ewhy\u003c\/em\u003e a specific choice was made – and \u003cstrong data-start=\"611\" data-end=\"639\"\u003ewhether it is defensible\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-start=\"642\" data-end=\"917\"\u003eThis guide is designed for \u003cstrong data-start=\"669\" data-end=\"705\"\u003eQA, QC, QP, and RA professionals\u003c\/strong\u003e working under inspection pressure who must make \u003cstrong data-start=\"754\" data-end=\"800\"\u003efast, consistent, and defensible decisions\u003c\/strong\u003e, without wasting days interpreting fragmented regulations.\u003cbr data-start=\"859\" data-end=\"862\"\u003eIts purpose is \u003cstrong data-start=\"877\" data-end=\"916\"\u003eto save time, not to explain theory\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch2 data-start=\"924\" data-end=\"948\"\u003e\u003cstrong data-start=\"928\" data-end=\"948\"\u003eThe Real Problem\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-start=\"950\" data-end=\"995\"\u003eIn daily practice, this happens all the time:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"999\" data-end=\"1068\"\u003eSpecifications copied from pharmacopeias without real justification\u003c\/li\u003e\n\u003cli data-start=\"1071\" data-end=\"1156\"\u003eICH limits applied “by default,” without assessing the actual manufacturing process\u003c\/li\u003e\n\u003cli data-start=\"1159\" data-end=\"1233\"\u003eCompendial methods treated as black boxes, without in-house verification\u003c\/li\u003e\n\u003cli data-start=\"1236\" data-end=\"1312\"\u003eHighly variable bioassays that are difficult to explain during inspections\u003c\/li\u003e\n\u003cli data-start=\"1315\" data-end=\"1384\"\u003eDelayed decisions because USP, Ph. Eur., and ICH do not fully align\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1386\" data-end=\"1530\"\u003e\u003cstrong data-start=\"1386\" data-end=\"1401\"\u003eThe result?\u003c\/strong\u003e\u003cbr data-start=\"1401\" data-end=\"1404\"\u003eDocuments rewritten multiple times, uncertainty in front of inspectors, rework costing days and putting batch release at risk.\u003c\/p\u003e\n\u003cp data-start=\"1532\" data-end=\"1597\"\u003eThis guide was created precisely from these real-world scenarios.\u003c\/p\u003e\n\u003ch2 data-start=\"1604\" data-end=\"1638\"\u003e\u003cstrong data-start=\"1608\" data-end=\"1638\"\u003eThe Concrete Value You Get\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-start=\"1640\" data-end=\"1665\"\u003eWith this guide, you can:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"1669\" data-end=\"1738\"\u003eDrastically reduce audit preparation time for impurities and assays\u003c\/li\u003e\n\u003cli data-start=\"1741\" data-end=\"1810\"\u003eMake faster, more defensible decisions on limits and specifications\u003c\/li\u003e\n\u003cli data-start=\"1813\" data-end=\"1867\"\u003eAvoid common mistakes that lead to critical findings\u003c\/li\u003e\n\u003cli data-start=\"1870\" data-end=\"1932\"\u003eAlign ICH, USP, and Ph. Eur. without unnecessary duplication\u003c\/li\u003e\n\u003cli data-start=\"1935\" data-end=\"1985\"\u003eEnter audits with clear, ready-to-use rationales\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1987\" data-end=\"2064\"\u003eNo theoretical benefits.\u003cbr data-start=\"2011\" data-end=\"2014\"\u003e\u003cstrong data-start=\"2014\" data-end=\"2064\"\u003eReal time savings and reduced regulatory risk.\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch2 data-start=\"2071\" data-end=\"2102\"\u003e\u003cstrong data-start=\"2075\" data-end=\"2102\"\u003eWhat the Guide Contains\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-start=\"2104\" data-end=\"2177\"\u003eThis is not a collection of regulations.\u003cbr data-start=\"2144\" data-end=\"2147\"\u003eIt is an \u003cstrong data-start=\"2156\" data-end=\"2176\"\u003eoperational tool\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-start=\"2179\" data-end=\"2201\"\u003eInside, you will find:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"2205\" data-end=\"2265\"\u003ePractical interpretation of \u003cstrong data-start=\"2233\" data-end=\"2263\"\u003eICH Q3A\/B\/C\/D, M7, Q6A\/Q6B\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli data-start=\"2268\" data-end=\"2349\"\u003eOperational comparison of \u003cstrong data-start=\"2294\" data-end=\"2313\"\u003eUSP vs Ph. Eur.\u003c\/strong\u003e on impurities and critical assays\u003c\/li\u003e\n\u003cli data-start=\"2352\" data-end=\"2411\"\u003eClear criteria to define and justify specification limits\u003c\/li\u003e\n\u003cli data-start=\"2414\" data-end=\"2450\"\u003eStructured approach to impurities:\n\u003cul\u003e\n\u003cli data-start=\"2455\" data-end=\"2475\"\u003eorganic impurities\u003c\/li\u003e\n\u003cli data-start=\"2480\" data-end=\"2499\"\u003eresidual solvents\u003c\/li\u003e\n\u003cli data-start=\"2504\" data-end=\"2526\"\u003eelemental impurities\u003c\/li\u003e\n\u003cli data-start=\"2531\" data-end=\"2568\"\u003egenotoxic impurities \/ nitrosamines\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2571\" data-end=\"2653\"\u003ePractical management of compendial bioassays (variability, validation, trending)\u003c\/li\u003e\n\u003cli data-start=\"2656\" data-end=\"2693\"\u003eAudit-ready checklists for QA\/QC\/QP\u003c\/li\u003e\n\u003cli data-start=\"2696\" data-end=\"2752\"\u003eReal inspection error examples – and how to avoid them\u003c\/li\u003e\n\u003cli data-start=\"2755\" data-end=\"2836\"\u003eApplied \u003cstrong data-start=\"2763\" data-end=\"2792\"\u003erisk-based logic (ICH Q9)\u003c\/strong\u003e, ready to be explained during inspections\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2838\" data-end=\"2903\"\u003eEach section is designed to be \u003cstrong data-start=\"2869\" data-end=\"2889\"\u003eused immediately\u003c\/strong\u003e, not studied.\u003c\/p\u003e\n\u003ch2 data-start=\"2910\" data-end=\"2937\"\u003e\u003cstrong data-start=\"2914\" data-end=\"2937\"\u003eWhy Buy This Guide?\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-start=\"2939\" data-end=\"2965\"\u003eBecause it saves you from:\u003c\/p\u003e\n\u003cp data-start=\"2969\" data-end=\"3012\"\u003eRe-reading dozens of regulatory documents\u003c\/p\u003e\n\u003cp data-start=\"3015\" data-end=\"3068\"\u003eRe-interpreting ambiguous requirements from scratch\u003c\/p\u003e\n\u003cp data-start=\"3071\" data-end=\"3115\"\u003eRebuilding rationales under audit pressure\u003c\/p\u003e\n\u003cp data-start=\"3118\" data-end=\"3173\"\u003eRewriting documents because they are “not defensible”\u003c\/p\u003e\n\u003cp data-start=\"3175\" data-end=\"3241\"\u003eThe standards are already interpreted.\u003cbr data-start=\"3213\" data-end=\"3216\"\u003eThe decisions are guided.\u003c\/p\u003e\n\u003cp data-start=\"3243\" data-end=\"3358\"\u003eIf you work in QA\/QC, the price of this guide is \u003cstrong data-start=\"3292\" data-end=\"3336\"\u003elower than the cost of a single day lost\u003c\/strong\u003e in audit preparation.\u003c\/p\u003e\n\u003ch2 data-start=\"3365\" data-end=\"3404\"\u003e\u003cstrong data-start=\"3369\" data-end=\"3404\"\u003eWho It’s For – and Who It’s Not\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-start=\"3406\" data-end=\"3420\"\u003e\u003cstrong data-start=\"3406\" data-end=\"3420\"\u003eIdeal for:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"3424\" data-end=\"3443\"\u003eQuality Assurance\u003c\/li\u003e\n\u003cli data-start=\"3446\" data-end=\"3463\"\u003eQuality Control\u003c\/li\u003e\n\u003cli data-start=\"3466\" data-end=\"3489\"\u003eQualified Person (QP)\u003c\/li\u003e\n\u003cli data-start=\"3492\" data-end=\"3512\"\u003eRegulatory Affairs\u003c\/li\u003e\n\u003cli data-start=\"3515\" data-end=\"3536\"\u003eLaboratory Managers\u003c\/li\u003e\n\u003cli data-start=\"3539\" data-end=\"3576\"\u003eValidation \/ Analytical Development\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3578\" data-end=\"3609\"\u003e\u003cstrong data-start=\"3578\" data-end=\"3609\"\u003eNot suitable for those who:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"3613\" data-end=\"3665\"\u003eAre looking for an introductory explanation of GMP\u003c\/li\u003e\n\u003cli data-start=\"3668\" data-end=\"3716\"\u003eWant only a theoretical summary of regulations\u003c\/li\u003e\n\u003cli data-start=\"3719\" data-end=\"3754\"\u003eDo not make operational decisions\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3756\" data-end=\"3950\"\u003eThis guide is written by professionals who have \u003cstrong data-start=\"3804\" data-end=\"3831\"\u003eexperienced real audits\u003c\/strong\u003e, \u003cstrong data-start=\"3833\" data-end=\"3883\"\u003edefended specifications in front of inspectors\u003c\/strong\u003e, and understand the \u003cstrong data-start=\"3904\" data-end=\"3949\"\u003epractical differences between EMA and FDA\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-start=\"3952\" data-end=\"4077\"\u003eAudit-ready. Risk-based.\u003cbr data-start=\"3976\" data-end=\"3979\"\u003eAligned with current inspection expectations.\u003cbr data-start=\"4024\" data-end=\"4027\"\u003eNo unnecessary theory – only defensible decisions.\u003c\/p\u003e\n\u003ch2 data-start=\"4084\" data-end=\"4107\"\u003e\u003cstrong data-start=\"4088\" data-end=\"4107\"\u003eProduct Details\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli data-start=\"4111\" data-end=\"4141\"\u003e\u003cstrong data-start=\"4111\" data-end=\"4122\"\u003eFormat:\u003c\/strong\u003e Professional PDF\u003c\/li\u003e\n\u003cli data-start=\"4144\" data-end=\"4166\"\u003e\u003cstrong data-start=\"4144\" data-end=\"4155\"\u003eLength:\u003c\/strong\u003e 62 pages\u003c\/li\u003e\n\u003cli data-start=\"4169\" data-end=\"4197\"\u003e\u003cstrong data-start=\"4169\" data-end=\"4181\"\u003eUpdated:\u003c\/strong\u003e February 2026\u003c\/li\u003e\n\u003cli data-start=\"4200\" data-end=\"4226\"\u003e\u003cstrong data-start=\"4200\" data-end=\"4214\"\u003eLanguages:\u003c\/strong\u003e ITA – ENG\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"4228\" data-end=\"4263\"\u003e\u003cstrong data-start=\"4228\" data-end=\"4263\"\u003eDOWNLOAD A PREVIEW OF THE GUIDE\u003c\/strong\u003e\u003c\/p\u003e\n\u003ctable class=\"MsoTableGrid\" border=\"1\" cellspacing=\"0\" cellpadding=\"0\" width=\"54%\" style=\"width: 54.1%; border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt;\"\u003e\n\u003ctbody\u003e\n\u003ctr style=\"mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes;\"\u003e\n\u003ctd width=\"48%\" valign=\"top\" style=\"width: 48.2%; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\"\u003e\n\u003cp class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 115%; text-align: center;\"\u003e\u003ca rel=\"noopener\" href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/Guida_alle_Farmacopee_Impurita_e_Saggi_Critici_Multi-Regione_ICH_vs_Compendi__PREVIEW.pdf?v=1770548544\" target=\"_blank\"\u003e\u003cb\u003ePreview ITA \u003c\/b\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd width=\"50%\" valign=\"top\" style=\"width: 50.9%; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\"\u003e\n\u003cp class=\"MsoNormal\" style=\"margin-bottom: 8pt; line-height: 115%; text-align: center;\"\u003e\u003ca rel=\"noopener\" href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/Guide_to_Pharmacopoeias_Impurities_and_Critical_Assays_Multi-Region_ICH_vs_Compendia__PREVIEW.pdf?v=1770548584\" target=\"_blank\"\u003e\u003cb\u003eP\u003c\/b\u003e\u003cb style=\"font-size: 0.875rem;\"\u003e\u003c\/b\u003e\u003cb style=\"font-size: 0.875rem;\"\u003ereview ENG\u0026nbsp;\u003c\/b\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e","brand":"GuideGxP","offers":[{"title":"ENG - English","offer_id":61047195009354,"sku":null,"price":149.0,"currency_code":"EUR","in_stock":true},{"title":"ITA- Italiano","offer_id":61047195042122,"sku":null,"price":149.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/Pharmacopoeias_impurities_COVER.png?v=1770548451"},{"product_id":"farmacopee-audit-gmp-gestione-usp-ph-eur","title":"Pharmacopeias and GMP Audits: Operational Management of USP, Ph. Eur. and Multi-Regional Compliance During Inspections","description":"\u003cp data-start=\"236\" data-end=\"558\"\u003ePharmacopeias are among the most critical — and most underestimated — topics during a GMP audit.\u003cbr data-start=\"332\" data-end=\"335\"\u003eUSP, Ph. Eur. and compendial requirements are not assessed only “on paper”: inspectors verify how they are actually applied in the laboratory, in analytical methods, reference standards and day-to-day operational decisions.\u003c\/p\u003e\n\u003cp data-start=\"560\" data-end=\"769\"\u003eFollowing the regulation is not enough.\u003cbr data-start=\"599\" data-end=\"602\"\u003eDuring an EMA, FDA or PIC\/S inspection, what really matters is demonstrating control, consistency and defensible decisions — especially in multi-regional environments.\u003c\/p\u003e\n\u003cp data-start=\"771\" data-end=\"969\"\u003eThis guide is based on real GMP inspection experience and is designed for QA, QC and QP professionals working under pressure who need to prepare quickly, without weak or theoretical interpretations.\u003c\/p\u003e\n\u003cp data-start=\"971\" data-end=\"1104\"\u003eIt does not explain what the pharmacopeia says.\u003cbr data-start=\"1018\" data-end=\"1021\"\u003eIt tells you how to use it, how to defend it in an audit and how to avoid findings.\u003c\/p\u003e\n\u003ch2 data-start=\"1111\" data-end=\"1134\"\u003e\u003cstrong data-start=\"1114\" data-end=\"1134\"\u003eThe Real Problem\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-start=\"1136\" data-end=\"1179\"\u003eIn everyday practice, this is what happens:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"1183\" data-end=\"1239\"\u003ePharmacopeias are long, fragmented and often ambiguous\u003c\/li\u003e\n\u003cli data-start=\"1242\" data-end=\"1315\"\u003eUSP and Ph. Eur. do not always align, and no one explains how to choose\u003c\/li\u003e\n\u003cli data-start=\"1318\" data-end=\"1385\"\u003e“Compendial” methods are applied out of habit, not out of control\u003c\/li\u003e\n\u003cli data-start=\"1388\" data-end=\"1449\"\u003eReference standards are poorly managed or taken for granted\u003c\/li\u003e\n\u003cli data-start=\"1452\" data-end=\"1536\"\u003eDocuments are rewritten multiple times because no one is sure they are audit-proof\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1538\" data-end=\"1702\"\u003eDuring an audit, inspectors ask the questions that hit hardest:\u003cbr data-start=\"1601\" data-end=\"1604\"\u003e“Why did you choose this method?”\u003cbr data-start=\"1637\" data-end=\"1640\"\u003e“How do you demonstrate that it also covers the other market?”\u003c\/p\u003e\n\u003cp data-start=\"1704\" data-end=\"1783\"\u003eThe result?\u003cbr data-start=\"1715\" data-end=\"1718\"\u003eSlow decisions, unnecessary stress and avoidable inspection risk.\u003c\/p\u003e\n\u003ch2 data-start=\"1790\" data-end=\"1823\"\u003e\u003cstrong data-start=\"1793\" data-end=\"1823\"\u003eThe Concrete Value You Get\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-start=\"1825\" data-end=\"1853\"\u003eWith this guide you achieve:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"1857\" data-end=\"1904\"\u003eA drastic reduction in audit preparation time\u003c\/li\u003e\n\u003cli data-start=\"1907\" data-end=\"1960\"\u003eFaster, defensible decisions in front of inspectors\u003c\/li\u003e\n\u003cli data-start=\"1963\" data-end=\"2011\"\u003eLess rework on SOPs, methods and documentation\u003c\/li\u003e\n\u003cli data-start=\"2014\" data-end=\"2085\"\u003eReal control over methods, standards, impurities and compendial tests\u003c\/li\u003e\n\u003cli data-start=\"2088\" data-end=\"2130\"\u003eLower risk of Major or Critical findings\u003c\/li\u003e\n\u003cli data-start=\"2133\" data-end=\"2201\"\u003eGreater confidence in managing multi-regional products and batches\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2203\" data-end=\"2235\"\u003eOperational benefits. No theory.\u003c\/p\u003e\n\u003ch2 data-start=\"2242\" data-end=\"2272\"\u003e\u003cstrong data-start=\"2245\" data-end=\"2272\"\u003eWhat the Guide Contains\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-start=\"2274\" data-end=\"2335\"\u003eThe guide is structured to be used immediately — not studied:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"2339\" data-end=\"2404\"\u003ePractical analysis of how inspectors actually use pharmacopeias\u003c\/li\u003e\n\u003cli data-start=\"2407\" data-end=\"2439\"\u003eMost frequently inspected areas:\n\u003cul\u003e\n\u003cli data-start=\"2444\" data-end=\"2464\"\u003ecompendial methods\u003c\/li\u003e\n\u003cli data-start=\"2469\" data-end=\"2490\"\u003ereference standards\u003c\/li\u003e\n\u003cli data-start=\"2495\" data-end=\"2508\"\u003edissolution\u003c\/li\u003e\n\u003cli data-start=\"2513\" data-end=\"2525\"\u003eimpurities\u003c\/li\u003e\n\u003cli data-start=\"2530\" data-end=\"2544\"\u003emicrobiology\u003c\/li\u003e\n\u003cli data-start=\"2549\" data-end=\"2582\"\u003einstrumentation and calibration\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2585\" data-end=\"2624\"\u003eReal findings and why they are raised\u003c\/li\u003e\n\u003cli data-start=\"2627\" data-end=\"2681\"\u003eDecision flows to manage USP vs Ph. Eur. divergences\u003c\/li\u003e\n\u003cli data-start=\"2684\" data-end=\"2720\"\u003eConcrete examples of audit defense\u003c\/li\u003e\n\u003cli data-start=\"2723\" data-end=\"2760\"\u003eReady-to-use audit-ready checklists\u003c\/li\u003e\n\u003cli data-start=\"2763\" data-end=\"2819\"\u003eClear guidance on what must be ready before inspection\u003c\/li\u003e\n\u003cli data-start=\"2822\" data-end=\"2875\"\u003eRisk-based approach aligned with EMA, FDA and PIC\/S\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2877\" data-end=\"2965\"\u003eEach chapter is designed to answer one question:\u003cbr data-start=\"2925\" data-end=\"2928\"\u003e\u003cstrong data-start=\"2928\" data-end=\"2965\"\u003e“What do I need to do right now?”\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch2 data-start=\"2972\" data-end=\"2998\"\u003e\u003cstrong data-start=\"2975\" data-end=\"2998\"\u003eWhy Buy This Guide?\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-start=\"3000\" data-end=\"3008\"\u003eBecause:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"3012\" data-end=\"3053\"\u003eThe regulations are already interpreted\u003c\/li\u003e\n\u003cli data-start=\"3056\" data-end=\"3090\"\u003eOperational decisions are guided\u003c\/li\u003e\n\u003cli data-start=\"3093\" data-end=\"3125\"\u003eCritical areas are anticipated\u003c\/li\u003e\n\u003cli data-start=\"3128\" data-end=\"3184\"\u003eFinding-generating weaknesses are addressed in advance\u003c\/li\u003e\n\u003cli data-start=\"3187\" data-end=\"3231\"\u003eYou avoid starting from scratch every time\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3233\" data-end=\"3342\"\u003eThe cost of the guide is a fraction of the time it saves —\u003cbr data-start=\"3291\" data-end=\"3294\"\u003eand far less than the cost of a serious finding.\u003c\/p\u003e\n\u003ch2 data-start=\"3349\" data-end=\"3387\"\u003e\u003cstrong data-start=\"3352\" data-end=\"3387\"\u003eWho It’s For (and Who It’s Not)\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-start=\"3389\" data-end=\"3403\"\u003e\u003cstrong data-start=\"3389\" data-end=\"3403\"\u003eIdeal for:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"3407\" data-end=\"3435\"\u003eQuality Assurance Managers\u003c\/li\u003e\n\u003cli data-start=\"3438\" data-end=\"3471\"\u003eQC Managers and senior analysts\u003c\/li\u003e\n\u003cli data-start=\"3474\" data-end=\"3498\"\u003eQualified Persons (QP)\u003c\/li\u003e\n\u003cli data-start=\"3501\" data-end=\"3564\"\u003eRegulatory Affairs professionals in multi-market environments\u003c\/li\u003e\n\u003cli data-start=\"3567\" data-end=\"3610\"\u003eLaboratories exporting to both EU and USA\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3612\" data-end=\"3636\"\u003e\u003cstrong data-start=\"3612\" data-end=\"3636\"\u003eNot suitable if you:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"3640\" data-end=\"3684\"\u003eAre looking for a basic regulatory summary\u003c\/p\u003e\n\u003cp data-start=\"3687\" data-end=\"3717\"\u003eDo not participate in audits\u003c\/p\u003e\n\u003cp data-start=\"3720\" data-end=\"3755\"\u003eDo not make operational decisions\u003c\/p\u003e\n\u003cp data-start=\"3757\" data-end=\"3933\"\u003eThis guide is built on real field experience, not theoretical interpretations.\u003cbr data-start=\"3835\" data-end=\"3838\"\u003eIt is designed for those who must \u003cstrong data-start=\"3872\" data-end=\"3906\"\u003edefend decisions during audits\u003c\/strong\u003e, not just understand them.\u003c\/p\u003e\n\u003cp data-start=\"3935\" data-end=\"4014\"\u003eOperational, audit-ready approach aligned with EMA, FDA and PIC\/S expectations.\u003c\/p\u003e\n\u003ch2 data-start=\"4021\" data-end=\"4043\"\u003e\u003cstrong data-start=\"4024\" data-end=\"4043\"\u003eProduct Details\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli data-start=\"4047\" data-end=\"4077\"\u003e\u003cstrong data-start=\"4047\" data-end=\"4058\"\u003eFormat:\u003c\/strong\u003e Professional PDF\u003c\/li\u003e\n\u003cli data-start=\"4080\" data-end=\"4102\"\u003e\u003cstrong data-start=\"4080\" data-end=\"4091\"\u003eLength:\u003c\/strong\u003e 69 pages\u003c\/li\u003e\n\u003cli data-start=\"4105\" data-end=\"4133\"\u003e\u003cstrong data-start=\"4105\" data-end=\"4117\"\u003eUpdated:\u003c\/strong\u003e February 2026\u003c\/li\u003e\n\u003cli data-start=\"4136\" data-end=\"4162\"\u003e\u003cstrong data-start=\"4136\" data-end=\"4150\"\u003eLanguages:\u003c\/strong\u003e ITA – ENG\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"4164\" data-end=\"4199\"\u003e\u003cstrong data-start=\"4164\" data-end=\"4199\"\u003eDOWNLOAD A PREVIEW OF THE GUIDE\u003c\/strong\u003e\u003c\/p\u003e\n\u003ctable style=\"width: 54.1%; border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt;\" width=\"54%\" cellpadding=\"0\" cellspacing=\"0\" border=\"1\" class=\"MsoTableGrid\"\u003e\n\u003ctbody\u003e\n\u003ctr style=\"mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes;\"\u003e\n\u003ctd style=\"width: 48.2%; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"48%\"\u003e\n\u003cp style=\"margin-bottom: 8pt; line-height: 115%; text-align: center;\" class=\"MsoNormal\"\u003e\u003ca rel=\"noopener\" href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/Guida_alle_Farmacopee_Audit_GMP_prepararsi_ispezioni_in_contesti_multi-regione_PREVIEW.pdf?v=1770549684\" target=\"_blank\"\u003e\u003cb\u003ePreview ITA \u003c\/b\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd style=\"width: 50.9%; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;\" valign=\"top\" width=\"50%\"\u003e\n\u003cp style=\"margin-bottom: 8pt; line-height: 115%; text-align: center;\" class=\"MsoNormal\"\u003e\u003ca rel=\"noopener\" href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/Guide_to_Pharmacopoeias_GMP_Audits_and_Pharmacopoeia_Compliance_PREVIEW.pdf?v=1770549720\" target=\"_blank\"\u003e\u003cb\u003eP\u003c\/b\u003e\u003cb style=\"font-size: 0.875rem;\"\u003e\u003c\/b\u003e\u003cb style=\"font-size: 0.875rem;\"\u003ereview ENG\u0026nbsp;\u003c\/b\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e","brand":"GuideGxP","offers":[{"title":"ENG - English","offer_id":61047780999498,"sku":null,"price":149.0,"currency_code":"EUR","in_stock":true},{"title":"ITA- Italiano","offer_id":61047781032266,"sku":null,"price":149.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/Pharmacopeias_inspection_GMP_COVER.png?v=1770549590"}],"url":"https:\/\/www.guidegxp.com\/collections\/gmp-guides-for-qc-labs-data-integrity-pharmacopeias-audit.oembed","provider":"GuideGxP","version":"1.0","type":"link"}